Lamivudine Therapy of WHV-Infected Woodchucks

This publication has 30 references indexed in Scilit:

• Inhibitory Effect of 2′-Fluoro-5-Methyl-β- l -Arabinofuranosyl-Uracil on Duck Hepatitis B Virus Replication
  Antimicrobial Agents and Chemotherapy, 1998
• Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
  Science, 1997
• Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
  The Lancet, 1997
• Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.
  Proceedings of the National Academy of Sciences, 1996
• A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
  New England Journal of Medicine, 1995
• Hepatitis B Virus Immunopathogenesis
  Annual Review of Immunology, 1995
• Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus
  Antimicrobial Agents and Chemotherapy, 1994
• Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus
  Antimicrobial Agents and Chemotherapy, 1993
• Enzyme‐altered Liver Cell Foci in Woodchucks Infected with Woodchuck Hepatitis Virus
  Japanese Journal of Cancer Research, 1988
• Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome
  Virology, 1988